secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2026-10-16T21:16:05+00:00
Accession:  0001437749-26-032828
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

NRx Pharmaceuticals sets 2026 annual meeting for Dec 17, record date Oct 28
---------------------------------------------------------------------------

- Board set Dec 17, 2026 as 2026 Annual Meeting date; record date Oct 28, 2026; meeting is virtual-only by live webcast at 10:00 a.m. ET.
- Meeting is more than 30 days before the March 23, 2025... 2025 Annual Meeting anniversary (held March 23, 2026), voiding prior proxy deadlines.
- Revised Rule 14a-8 stockholder proposal deadline: close of business Oct 25, 2026, to the Secretary at 1201 Orange Street, Suite 600, Wilmington, DE.
- Advance-notice deadline for proposals and director nominations under the Second Amended and Restated Bylaws is also close of business Oct 25, 2026; later notices untimely.
- Rule 14a-19 universal proxy notice deadline set at Oct 26, 2026 for stockholders soliciting alternative director nominees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000143774926032828/0001437749-26-032828-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000143774926032828/nrxp20261014_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-032828

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer